Sage Therapeutics’ Zulresso is a big win for postpartum depression sufferers — and maybe even the entire mental health community – CNBC

Sage Therapeutics’ Zulresso is a big win for postpartum depression sufferers — and maybe even the entire mental health community  CNBC

In June, Zulresso — the first and only medicine approved by the Food and Drug Administration to specifically treat postpartum depression — will hit the market.

Posted on Saturday, April 27th, 2019 at 6:45 am. Filed under: News Feeds RSS 2.0 feed.